Elena J. Orlando

Novartis (United States) ORCID: 0009-0004-6448-8874

1

h-index

1

Publications

1,614

Citations

Publications

1 shown

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta , Simon F. Lacey , Elena J. Orlando +34 more

2018 Nature Medicine 1614 citations

Frequent Co-Authors

Joseph A. Fraietta

Parker Institute for Cancer Immunotherapy

Simon F. Lacey

University of Pennsylvania

Iulian Pruteanu-Malinici

Novartis (United States)

Mercy Gohil

University of Pennsylvania

Stefan Lundh

University of Pennsylvania

Alina C. Boesteanu

University of Pennsylvania

Researcher Info

h-index: 1
Publications: 1
Citations: 1,614
Institution: Novartis (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0009-0004-6448-8874

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.